| Literature DB >> 25824942 |
Ewa Wons1, Beata Furmanek-Blaszk1, Marian Sektas2.
Abstract
DNA-dependent T7 RNA polymerase (T7 RNAP) is the most powerful tool for both gene expression and in vitro transcription. By using a Next Generation Sequencing (NGS) approach we have analyzed the polymorphism of a T7 RNAP-generated mRNA pool of the mboIIM2 gene. We find that the enzyme displays a relatively high level of template-dependent transcriptional infidelity. The nucleotide misincorporations and multiple insertions in A/T-rich tracts of homopolymers in mRNA (0.20 and 0.089%, respectively) cause epigenetic effects with significant impact on gene expression that is disproportionally high to their frequency of appearance. The sequence-dependent rescue of single and even double InDel frameshifting mutants and wild-type phenotype recovery is observed as a result. As a consequence, a heterogeneous pool of functional and non-functional proteins of almost the same molecular mass is produced where the proteins are indistinguishable from each other upon ordinary analysis. We suggest that transcriptional infidelity as a general feature of the most effective RNAPs may serve to repair and/or modify a protein function, thus increasing the repertoire of phenotypic variants, which in turn has a high evolutionary potential.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25824942 PMCID: PMC4417176 DOI: 10.1093/nar/gkv269
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Synthesis of the wild type M2.MboII methyltransferase from the mutated gene mboIIM2ΔA356 through the frameshifting mechanism. (A) Overproduction of M2.MboII protein in T7 phage expression system. Protein lysate was resolved by 10%-SDS-PAGE and stained with Coomassie blue. Lane 1, molecular size markers. Lane 2, lysate of non-induced E. coli ER2566 with pET24mboIIMB.4 carrying mboIIM2ΔA356. Lane 3, lysate of IPTG induced ER2566. Black arrow—position of full-length M2.MboII (32 kDa), white arrow—M2.MboIIΔA356 truncated variant (14.5 kDa). (B) Immunodetection of western-blotted M2.MboII protein variants. Lane 1, lysate of IPTG induced ER2566 with pET24mboIIMB.4. Lane 2, 1.5 μg of purified WT M2.MboII. Lanes 3 and 4, eluates of fractions #33 and #45 after phosphocellulose (P-11) chromatography (see panel D). (C) Autoradiogram of protein profile after 1mM IPTG induction of expression of mboIIM2 in ER2566 bacteria. A pulse-labeling with 35S-methionine following 1.5 h rifampicin blockage of the host's transcription after 1.5 h IPTG induction was performed. Lane 1, strain with pETmboMB.3 carrying WT gene; lane 2, strain with pETmboMB.4 carrying mboIIM2ΔA356. (D) DNA methylation assay. Top: fractions after phosphocellulose chromatography separated by SDS-PAGE stained with Coomassie. Middle: western-blotting with anti-M2.MboII serum. Bottom: M2.MboII specific activity (cpm) in subsequent fractions using 3H-AdoMet cofactor and DNA substrates containing specific 5′-TCTTC sequences (plasmid pUC18 [squares] and oligoduplex DNA C1 + C2 [diamonds]) or nonspecific sequence 5′-TGTTC (oligoduplex, DNA C3 + C4, [triangles]) (Supplementary Table S2).
Frequency of insertion at the A/T homopolymer hot spots in 376 nt mRNA of the mboIIM2ΔA356 proximal part
| Position of the first nucleotide of the homopolymer run (length) | Fraction of total reads showing insertions (%) (number of insertion reads/total reads per base) | Homoinsertion length detected | Fraction of the insertions having a given length (%) |
|---|---|---|---|
| 13T (6) | 1.06 (316/29 898) | T | 93.7 |
| TT | 5.4 | ||
| TTT | 0.9 | ||
| 279A (7) | 3.78 (3261/86 286) | A | 88.8 |
| AA | 8.8 | ||
| AAA | 1.9 | ||
| 351A (5) | 10.47 (9603/91 678) | 66.9 | |
| AA | 7.4 | ||
| AAA | 5.5 | ||
| 12.8 | |||
| AAAAA | 2.1 | ||
| AAAAAA | 1.0 | ||
| 2.3 | |||
| 364T (7) | 1.19 (1049/87 793) | 98.7 | |
| TT | 1.2 | ||
| TTT | 0.1 |
Coordinates according to the mboIIM2 gene sequence deposited in GenBank KM192157. For the purpose of this study we define a homopolymer as three or more adjacent nucleotides. Note, that in mRNA there are Us instead of Ts. A/Ts underlined restore the frame of reading for the mboIIM2ΔA356 gene.
Figure 2.Elimination of transcriptional slippage by systematic discontinuity of T/A homopolymeric tracts in the 346–375 nt region of the mboIIM2ΔA356 gene. (A) Four of the simplest ways to restore a A356 deletion by single nucleotide insertion (plus arrow) through a transcriptional slippage mechanism and their influence on amino acid sequence changes (underlined). The T/A homopolymer runs (underlined) are named L-tract, M and R-tract, respectively. (B). A set of site-specific mutagenized mboIIM2ΔA356 genes with interrupted poly(T + A) tracts. Short names are used (see Supplementary Table S1). (C) Immunodetection of M2.MboII in total protein extracts from cultures harboring plasmids with various replacement mutations of the mboIIM2ΔA356 gene. Bacterial lysates were run on Tricine-SDS–12.5% PAGE, western blotted and immunodetected against M2.MboII protein. DnaA protein was used as an internal marker. M—molecular size markers (Fermentas) including the M2.MboII protein. (D) The relative level of plasmid methylation by the individual M2.MboII mutated variant. Plasmid DNA was digested with R.MboII, resolved by 0.8% agarose gel electrophoresis and visualized with ethidium bromide. Lanes 1–9 correspond to the variants from panel (C). M—molecular weight marker 1 kb (Fermentas). 0—undigested pET-(A5)LMR6 plasmid. Inverted image of the gel is shown.
List of InDel mutations assayed by the T7 RNAP in vivo transcription of the mboIIM2 gene
| InDel location | Sequence context of InDel sites(1) | Full-length protein/MTase activity(2) | Possible restoration of gene continuity by transcriptional slippage mode(3) |
|---|---|---|---|
| None (WT) | (106)..GCC AAA GAT TGG TTA | +++/+++ | |
| (311)..AT ATT TTT GAT TTA AAT AG | |||
| (346)..ATT TTA AAA AAC ACC | |||
| (361)..AAA CTT TTT TTA ATG G | |||
| (616)..TTT GGC GTG CAT TCA GCG | |||
| ΔG112 | (106)..GCC AAA | +/++ | +A113 ..GCC AAA |
| ΔG112/ΔA356 | (106)..GCC AAA | −/− | +A113/+A356 ..AAA |
| (346).. | |||
| ΔT327 | (311)..AT ATT TTT GAT TTA | +/+++ | +A328 ..ATT TTT GAT TTA |
| +T323 ..ATT TTT GAT | |||
| ΔT327/ΔA328 | (311)..AT ATT TTT GAT TTA | ++/− | +T324/+A328 ..AT ATT TTT GAT |
| +2A327 ..AT ATT TTT GAT TTA | |||
| ΔA356 | (346)..ATT TTA AAA | +++/+++ | +A356 ..ATT TTA AAA A |
| …(362) | +T372 .. | ||
| ΔA356/A372C/G374C | (346)..ATT TTA AAA | +++/+++ | +A356 ..ATT TTA AAA A |
| (361) | +T371 .. | ||
| ΔA355/ΔA356 | (346)..ATT TTA AAA | ++/++ | +2A355 ..ATT TTA AAA |
| +A355/+T371 ..ATT TTA AAA | |||
| +T372 | (361)..AAA CTT TTT | +++/+++ | ΔT372 .. |
| +2A 357 ..ATT TTA AAA | |||
| ΔA356/ΔT371 | (346)..ATT TTA AAA | ++/+ | +2A 356 ..ATT TTA AAA |
| (361).. | +A356/+T371 ..ATT TTA AAA A | ||
| +2T370 .. | |||
| ΔA356/+T371 | (346)..ATT TTA AAA | +++/+++ | +T371 insertion compensate the A356 deletion, restoring itself to the original frame from this point |
| (361).. | |||
| ΔA630 | (616)..TTT GGC GTG CAT | −/− | +T619 ..TTT |
| C621G/ΔA630 | (616)..TTT GG[ | −/− | +G623 ..TTT GGG |
(1)Coordinates according to the mboIIM2 gene sequence deposited in GenBank KM192157.
(2)Relative production of full-length M2.MboII protein (32 kDa) in comparison to the wild type/relative methylation activity level (evaluated by plasmid protection assay). (+++) high, (++) medium, (+) low, (−) none.
(3)For simplicity T nucleotide was used instead of U nucleotide.
(4)Amino acid composition LKNTKLF (117–123) confirmed by Edman degradation analysis.
(5)Amino acid composition (a) LFLMDTYLWNR (122–132), (b) FLMDTYLWNR (119–132) and (c) TILK (115–122) confirmed by LC–MS-MS/MS mass spectrometry analysis after trypsin (a,b), or pepsin (c) proteolysis of the M2.MboIIΔA356.
Legend: (Δ) nucleotide deletion; () nucleotide insertion; ([G]) nucleotide replacement; italization—changes affecting the reading frame causing codon(s)/(amino acid(s) alteration in comparison to the wild type.
Figure 4.Synthesis of the full-length M2.MboII protein after epigenetic frameshift repair of some InDel mutations of the mboIIM2 gene. (A) Equal amounts of total protein extracts from cultures harboring plasmids with various InDel mutations (lanes 1–9) were analyzed after Tricine-SDS-PAGE and western blotting using anti-M2.MboII antibodies. Lane 10, molecular size markers (Fermentas) including purified M2.MboII protein. Black arrow—position of the full-length M2.MboII (32 kDa); white arrow—position of short M2.MboII variants; asterisk—shorter variant of M2.MboII product (21.71 kDa). (B) The relative protection level of the MboII sites in plasmids bearing the selected mboIIM2 InDel mutants against R.MboII digestion. Plasmid aliquots from non-induced (lanes 1–2, 5–6, 9–10, 13–14, 17–18, 21–22) and IPTG -induced cultures (3–4, 7–8, 11–12, 15–16, 19–20, 23–24) were digested with R.MboII (+). DNA was resolved by 0.8% agarose gel electrophoresis and visualized with ethidium bromide. Samples 17–20 and 21–24 were run on separate gels. Inverted image is shown.
Figure 3.Monitoring of T7 RNAP-based frameshifting by identification of the A356 deletion mutant and wild-type M2.MboIIΔ377(378)-GFP hybrid protein products. (A) The nucleotide sequence of the junction site in four mboIIM2Δ377(378)gfp fusion genes. Note, the triplets indicate the zero frame codons and only mboIIM2wtΔ378gfp0 should produce the hybrid protein in this frame (the gfp part of the fusion gene is marked in green). BamHI recognition site is marked in red, italicized nucleotides mean failure of Gfp recovery in 0 frame. (B) Images show fluorescence microscopy of induced E. coli ER2566 containing four plasmids with an appropriate mboIIM2gfp gene. DAPI and FM4-64 were added to stain DNA and cell membrane, respectively. Scale bar ≈ 10 μm. (C) Immunodetection of M2.MboIIΔA356Δ377-GFP hybrids by anti-M2.MboII rabbit polyclonal antibody/anti-rabbit-AP and anti-GFP mouse monoclonal/anti-mouse-HRP. The positions of the hybrid (H), GFP, full-length (WT) and short-form (Δ) M2.MboII proteins are indicated by arrows. (D) Immunodetection of the M2.MboIIwtΔ378-GFP hybrids (H) by anti-M2.MboII rabbit polyclonal antibody/anti-rabbit-AP and anti-GFP mouse monoclonal/anti-mouse-HRP.